Voices @ Research: The Trouble with Post-Stroke Cognitive Impairment
Clinical Research Coordinator Russell Chander, at the National Neuroscience Institute (NNI), Singapore General Hospital, main research focus is identifying useful in vitro biomarkers for early detection and prognostic prediction of neurocognitive disorders. His team is currently working on identifying stroke patients at risk of developing post-stroke cognitive impairment (PSCI) using prediction scales and scoring systems. Read his thoughts on this significant public health issue, the challenges and risks patients face and how their research can help improve stroke management.
Lean Populations: Are You Skinny, but Fat?
A joint study by Singapore General Hospital (SGH) and Duke-NUS Medical School has suggested that the effects of diabetes and liver disease may be more severe in lean populations. Lean people with a high body fat content have a higher risk of developing metabolic diseases such as diabetes. Dr Sonali Ganguly, Consultant, Department of Endocrinology, SGH, said that "Asians tend to accumulate more intra-abdominal (visceral) adipose tissue - the "harmful fat" that places them at a higher risk of metabolic disease." Read more about how these doctors weigh in on hidden body fat.
Unraveling Brain Diseases & Disorders
1st prize winners of the SingHealth Duke-NUS Research Team Award, Professor Tan Eng King from National Neuroscience Institute (NNI) and Assistant Professor Je Hyunsoo, Shawn from Duke-NUS Medical School will be sharing on their award-winning development of a living 3-dimension (3D) "mini-brain" at the upcoming Research Grand Round on 12 July, including the science of neuronal characteristics, dopaminergic replacement therapeutics in Parkinson's Disease and relationship between synapses, circuits and brain disorders. Register now for the session, which will be held at Academia's Seminar Room L1-S3.
Congratulations to SingHealth Excellence Awards 2017 Winners for Research Categories!
At the 7th SingHealth Excellence Awards held on 19 May, a total of seven SingHealth researchers were conferred the following: a Distinguished Researcher Award and a Distinguished Young Researcher Award under the SingHealth Excellence Awards; four researchers were conferred the Outstanding Clinician Researcher Award, and one for the Outstanding Administrative Staff Award under the GCEO Excellence Awards. These accolades are presented to honour outstanding professionals for their exemplary contributions to healthcare leadership, education, research and administration.
Fighting Myopia, One Eye-Drop At a Time
Singapore is known as the myopia capital of the world. The Singapore National Eye Centre (SNEC) is now embarking on a three and a half year study to determine if the use of atropine eye drops can prevent, or slow, the onset of myopia in young children with myopic parents, just before it starts or at the very early onset. Assoc Professor Audrey Chia, Head and Senior Consultant, Pediatric Ophthalmology and Adult Strabismus Department, SNEC, and investigator for the Atropine Treatment of Myopia 3 (ATOM 3) said this new study is a collaboration between the Singapore Eye Research Institute (SERI), Singapore Clinical Research Institute (SCRI) and SNEC. Read the full story here.
Seeing Dengue in a New Light
Researchers from Duke-NUS Medical School and Singapore General Hospital (SGH) have successfully used Positron Emission Technology (PET) to visualise dengue infection in real-time. This is the first time PET has been systematically evaluated for its use in the field of acute viral infectious diseases. PET enabled the detailed monitoring of the progression and severity of the infection, and assessment of the treatments' effectiveness in dengue-infected mice. "Being able to visualise dengue infection in the body potentially transforms how we assess the effectiveness of new dengue therapeutics" said Prof Subhas Vasudevan from the Emerging Infectious Disease (EID) Programme at Duke-NUS.